Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PMCID: PMC10617013
Understanding these research-backed protocols helps inform safe, effective therapeutic approaches under medical supervision
Shin and Gadde, 2013, "Clinical utility of phentermine/topiramate (Qsymia) combination for the treatment of obesity"
Discontinuation Rates Discontinuation rates due to adverse events in the Phase 2 trial were dose-dependent, ranging from approximately 6% in the 1 mg arm to 16% in the 12 mg arm
ASCT2 silencing substantially inhibits PC growth, resulting in decreased Gln consumption, -KG production, and ATP generation
Glutathione Whole Blood Controls, lyophilised 0077 Glutathione Whole Blood Control, Bi-Level I + II (lyoph.), 2 x 5 x 0.5 ml 0078 Glutathione Whole Blood Control, Level I (lyoph.), 5 x 0.5 ml 0079 Glutathione Whole Blood Control, Level II (lyoph.), 5 x 0.5 ml These lyophilised quality controls from Chromsystems are based on human whole blood and should be used according to the instruction manual
US$ 27.41
US$ 20.57
US$ 29.64
